Trial intelligence / Profile preview

Losartan for Hypoxia-Induced Sleep Disordered Breathing

NCT03335904Phase 4Completed

Sponsor
University of British Columbia
Start
Jan 2018
Primary completion
Aug 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of losartan in sleep disordered breathing (SDB), sponsored by University of British Columbia. Started Jan 2018; status: completed.

02

Drugs

losartan
03

Conditions

sleep disordered breathing (SDB)

Beyond the preview

Go deeper on NCT03335904.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03335904.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call